The potential of TB treatment 8 weeks

Published Date: 08 Mar 2023

While some say this strategy's failure rate is "too high," it's one step closer to the "white grail" of a shorter 24-week formula.

Read Full News

Latest News

Congo Begins Trial Of Gilead's Experimental Antiviral for Ebola Bundibugyo

Researchers in the Democratic Republic of Congo said on Tuesday they have started enrolling participants in ⁠a trial testing Gilead Sciences' experimental antiviral...

Gen Z Fitness Trend: Are Group Workouts Better?

Community fitness may improve exercise adherence and mental well-being through social support, although evidence shows that it offers few additional physical benefits.

What to Know About the US Outbreak Of Cyclosporiasis

The U.S. Centers for Disease Control and Prevention said on Tuesday it had confirmed 1,645 cases of an intestinal infection from the cyclospora parasite that causes...

Oxford Begins First Human Trial Of Bundibugyo Ebola Vaccine

The University of Oxford has launched the first human trial of a vaccine against Bundibugyo ebolavirus, seeking to accelerate ⁠efforts to combat an outbreak spreading in the...

Two- vs Three-Drug Combo for HIV Infection: No Clear Winner

Among treatment-naive adults living with HIV, CD4 to CD8 ratios do not differ significantly between those on dolutegravir plus lamivudine and those on integrase inhibitor-based three-drug regimens.

Nintedanib Shows No Benefit Over Placebo in Post-COVID ILD

Among patients with post-COVID interstitial lung disease, nintedanib does not provide significant benefit over placebo.

Todays Updates

Virtual Help Doubles Cancer Patients’ Smoking Quit Rate

Programs offering telehealth counseling and nicotine replacement products should be part of routine oncology care, researchers say.

MRD Tied to PFS in Lymphoma Patients on Epcoritamab

Researchers evaluate minimal residual disease status in 128 adults with relapsed or refractory follicular lymphoma treated with epcoritamab.

Germline Profiling May Improve Risk Stratification in t-MNs

A new study explores whether germline profiling could refine the subclassification and prognosis of therapy-related myeloid neoplasms beyond treatment history alone.

Todays Updates

Virtual Help Doubles Cancer Patients’ Smoking Quit Rate

Programs offering telehealth counseling and nicotine replacement products should be part of routine oncology care, researchers say.

MRD Tied to PFS in Lymphoma Patients on Epcoritamab

Researchers evaluate minimal residual disease status in 128 adults with relapsed or refractory follicular lymphoma treated with epcoritamab.

Germline Profiling May Improve Risk Stratification in t-MNs

A new study explores whether germline profiling could refine the subclassification and prognosis of therapy-related myeloid neoplasms beyond treatment history alone.

Latest News

Researchers in the Democratic Republic of Congo said on Tuesday they have started enrolling participants in ⁠a trial testing Gilead Sciences' experimental antiviral...

Community fitness may improve exercise adherence and mental well-being through social support, although evidence shows that it offers few additional physical benefits.

The U.S. Centers for Disease Control and Prevention said on Tuesday it had confirmed 1,645 cases of an intestinal infection from the cyclospora parasite that causes...

The University of Oxford has launched the first human trial of a vaccine against Bundibugyo ebolavirus, seeking to accelerate ⁠efforts to combat an outbreak spreading in the...

Among treatment-naive adults living with HIV, CD4 to CD8 ratios do not differ significantly between those on dolutegravir plus lamivudine and those on integrase inhibitor-based three-drug regimens.

Among patients with post-COVID interstitial lung disease, nintedanib does not provide significant benefit over placebo.

News All Time

Congo Bans Gatherings in Kinshasa and Three Provinces Over Ebola Outbreak

The Democratic Republic of Congo has banned public gatherings in four provinces, including the capital, Kinshasa, as ⁠the country battles a deadly Ebola...

Ebola Outbreak Could Cost Africa Up to $3.6 Billion, UN Says

(Edits headline to spell out 'billion')

Can Early Metformin Treatment Prevent Long COVID Symptoms?

Early metformin treatment in mild-to-moderate COVID may not prevent long-term symptoms but is linked to relatively fewer clinician-diagnosed cases, a study finds.

Africa CDC Seeks $18 Million in Urgent Support for Ebola Drug Trials in DRC

The Africa Centres for Disease Control and Prevention on Tuesday called for $18 million in urgent ⁠funding to support trials of experimental Ebola treatments in the...

WHO Issues Clinical Care Advice for Ebola

New recommendations focus on supportive care, shared decision-making, and infection control.

Congo Says Number Of Confirmed Ebola Cases At 1,274, Including 360 Deaths

⁠The Democratic ⁠Republic ⁠of Congo ‌said late on ‌Sunday that ‌confirmed ‌Ebola ⁠cases ‌in ⁠the country ‌had reached 1,274, including ‌360...

Antiretroviral Therapy

Review clinical reference information, guidelines, and medical news on antiretroviral therapy, HIV treatment, and AIDS treatment. Learn about antiretroviral treatment including antiretroviral medications and HIV drugs.

Congo Says Number Of Confirmed Ebola Cases Rises to 1,155

The number of confirmed ⁠Ebola cases in the Democratic Republic ⁠of Congo has increased to ⁠1,155, including ‌304 deaths, government data showed on Thursday.

EU Commission Opens Antitrust Probe Into Sanofi's Flu Vaccine Campaign

The European Commission opened an investigation on ⁠Friday into whether French drugmaker Sanofi breached EU competition ⁠rules in a flu vaccine marketing...

US Military Requires Flu Vaccine for Some After Outbreak in Texas Training Center

The U.S. military has resumed requiring flu vaccines for some service members in an exception to Defense ⁠Secretary Pete Hegseth's guidance declaring the shots voluntary two...

Africa CDC Says Funding Needs for Ebola Response Three Times Higher At $1.4 Billion

Africa's top public health agency said on Thursday that funding needed ⁠to tackle the continent's Ebola outbreak was three times higher than an earlier estimate, and now...

Australia Ramps Up Bird Flu Testing as Second State Reports Case

Australian authorities ramped up surveillance and testing of wildlife and livestock on Wednesday after a second state reported a case ⁠of the highly pathogenic H5N1 bird...

WHO Says Congo's Ebola Outbreak Still Fast-moving and Health Workers Under Threat

The Ebola outbreak in Democratic Republic of Congo is still outpacing response efforts, and frontline health workers there ⁠face very risky conditions, World Health...

Cytokine Scaffold Builds Long-Lived CAR T Cells Against HIV

A new approach aims to use CAR T cells to last longer in the fight against HIV.

UNICEF, Gavi Call to Speed Bundibugyo Ebola Vaccine Access

UNICEF and global vaccine group Gavi said on Wednesday they are seeking information from developers and manufacturers ⁠on plans for a vaccine against the Bundibugyo strain...

Ebola Infects More Than 1,000 in Congo, Spreads to Kill Toddler in New Camp

Ebola has now infected more than 1,000 people in the Democratic Republic of Congo in ⁠an outbreak that has spread to a third displacement camp and killed an 18-month-old...

Recommended News For You

Enhanced access for patients with prostate cancer is provided by the new SPECT/CT technique, which demonstrates remarkable biomarker identification.

Research uncovers hidden Australian skin cancer epidemic

A new therapeutic approach could help tackle radiation resistance in childhood brain tumors

Sustained reduction found in prostate cancer mortality with prostate-specific antigen screening

Venetoclax Combo Shows Promise in Younger Patients With AML

Gene Therapy for Rare Brain Disease Effective, but Comes With Blood Cancer Risk

Breast cancer: A new target to eliminate dormant cells before they wake

Recommended Articles For You

Unlocking the Potential of SCD: A Comprehensive Guide to Diagnosis and Treatment 

Decoding Granular Cell Tumor: What You Need to Know 

Understanding Cold Agglutinin Disease: Symptoms, Diagnosis, and Treatment Options  

Precision Medicine and Genomics: Revolutionizing Healthcare Through Personalized Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Reasons Behind Refusing Stem Cell Transplantation in Certain Myeloma Patients.

2.

Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study

3.

COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment

4.

A novel test shows promise for finding cervical adenocarcinoma, which is difficult to find.

5.

Lung nodules seen in a high percentage of non-smokers

1.

The Role of Alanine Aminotransferase in Liver Health and Disease 

2.

Potential of Device-Assisted Therapy in Non-Muscle-Invasive Bladder Cancer

3.

The Role of Calcium Corrections in Accurate Blood Test Results 

4.

Undersanding Alemtuzumab: What You Need To Know About This Multiple Sclerosis Medication

5.

Uncovering the Subtle Signs of Leukemia: A Guide to Early Detection

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks

2.

The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

4.

Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment

5.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot